Abstract
BackgroundRegular blood tests for monitoring metabolic side effects are often unable to be collected for people with an intellectual/developmental disability (ID/DD) and challenging behaviours (CBs) using usual pathways. We aimed...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have